Golden Throat Holdings Group Company Limited (6896.HK)
HKD 4.25
(-0.47%)
HKD 4.25
(-0.47%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 748.33 Million CNY | -1.56% |
| 2022 | 760.17 Million CNY | 29.27% |
| 2021 | 588.03 Million CNY | 26.53% |
| 2020 | 464.74 Million CNY | -1.71% |
| 2019 | 472.82 Million CNY | 10.28% |
| 2018 | 428.74 Million CNY | 2.65% |
| 2017 | 417.69 Million CNY | -6.27% |
| 2016 | 445.65 Million CNY | 33.83% |
| 2015 | 332.99 Million CNY | -30.14% |
| 2014 | 476.67 Million CNY | 13.64% |
| 2013 | 419.47 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q4 | 748.33 Million CNY | 41.92% |
| 2023 FY | 748.33 Million CNY | -1.56% |
| 2023 Q2 | 527.3 Million CNY | -30.63% |
| 2022 Q4 | 760.17 Million CNY | 48.94% |
| 2022 FY | 760.17 Million CNY | 29.27% |
| 2022 Q2 | 510.4 Million CNY | -13.2% |
| 2021 Q4 | 588.03 Million CNY | 16.53% |
| 2021 FY | 588.03 Million CNY | 26.53% |
| 2021 Q2 | 504.6 Million CNY | 8.58% |
| 2020 Q4 | 464.74 Million CNY | 7.08% |
| 2020 Q2 | 434.01 Million CNY | -8.21% |
| 2020 FY | 464.74 Million CNY | -1.71% |
| 2019 FY | 472.82 Million CNY | 10.28% |
| 2019 Q2 | 701.62 Million CNY | 63.65% |
| 2019 Q4 | 472.82 Million CNY | -32.61% |
| 2018 Q4 | 428.74 Million CNY | -3.44% |
| 2018 FY | 428.74 Million CNY | 2.65% |
| 2018 Q2 | 444.04 Million CNY | 6.31% |
| 2017 Q4 | 417.69 Million CNY | 26.88% |
| 2017 FY | 417.69 Million CNY | -6.27% |
| 2017 Q2 | 329.21 Million CNY | -26.13% |
| 2016 Q2 | 369.16 Million CNY | 10.86% |
| 2016 Q4 | 445.65 Million CNY | 20.72% |
| 2016 FY | 445.65 Million CNY | 33.83% |
| 2015 FY | 332.99 Million CNY | -30.14% |
| 2015 Q4 | 332.99 Million CNY | -3.37% |
| 2015 Q2 | 344.6 Million CNY | -27.71% |
| 2014 FY | 476.67 Million CNY | 13.64% |
| 2014 Q4 | 476.67 Million CNY | 0.0% |
| 2013 FY | 419.47 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 142.28 Million HKD | -425.954% |
| Grand Pharmaceutical Group Limited | 7.24 Billion HKD | 89.671% |
| Extrawell Pharmaceutical Holdings Limited | 170.4 Million HKD | -339.147% |
| Wai Yuen Tong Medicine Holdings Limited | 709.65 Million HKD | -5.451% |
| Qianhai Health Holdings Limited | 94 Million HKD | -696.079% |
| Lee's Pharmaceutical Holdings Limited | 930.06 Million HKD | 19.54% |
| Essex Bio-Technology Limited | 903.78 Million HKD | 17.199% |
| Tongfang Kontafarma Holdings Limited | 665.38 Million HKD | -12.466% |
| PuraPharm Corporation Limited | 689.65 Million HKD | -8.51% |
| SSY Group Limited | 4.49 Billion HKD | 83.348% |
| JBM (Healthcare) Limited | 366.75 Million HKD | -104.044% |
| Jacobson Pharma Corporation Limited | 1.09 Billion HKD | 31.376% |
| China Resources Pharmaceutical Group Limited | 168.46 Billion HKD | 99.556% |